1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pediatric Cancer Research Foundation Translational Research Grants is sponsored by Pediatric Cancer Research Foundation (PCRF). This grant primarily funds new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high-risk cancers.
It supports programs involving open, multi-institutional cancer clinical trials or consortia that implement new approaches to therapy.
Get alerted about grants like this
Get emailed when new opportunities from “Pediatric Cancer Research Foundation (PCRF)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Single or multi-institutional programs involving open, cancer clinical trials or consortia. LOI submissions are typically required from February 1st through April 1st. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000 per year (up to 2 years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 1, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Pediatric Cancer Research Foundation Translational Research Grants is funded by Pediatric Cancer Research Foundation (PCRF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.